What is the main purpose of this 10-Q filing?

This 10-Q filing provides HCA Healthcare, Inc.'s unaudited quarterly financial statements and management's analysis of its financial condition and results of operations for the period ended September 30, 2004. It allows investors to track the company's performance between its annual reports.

What does being an 'accelerated filer' mean for investors?

Being an accelerated filer means HCA meets certain SEC criteria for size and reporting history, suggesting a larger, more established company. It also requires more frequent and detailed financial reporting compared to non-accelerated filers.

Where can I find the specific financial performance details for the quarter?

Specific financial performance details, such as revenue, net income, and key operational metrics, can be found in the 'Condensed Consolidated Income Statements' and 'Management’s Discussion and Analysis of Financial Condition and Results of Operations' sections within the full 10-Q filing.

What is the significance of the share counts provided?

The share counts indicate the total number of voting and nonvoting common shares outstanding as of a recent date. This information is crucial for calculating key per-share metrics like Earnings Per Share (EPS) and for understanding the company's equity structure.

HCA 10-Q Quarterly Report Q3 FY2004 — Revenue, Net Income, EPS

Summary

HCA Healthcare, Inc. (HCA) reported its financial results for the quarterly period ended September 30, 2004. The company appears to be in stable financial standing, as indicated by its filing of all required reports and its status as an accelerated filer. Investors should note the specific share counts for voting and nonvoting common stock outstanding as of October 31, 2004. The filing includes unaudited condensed consolidated financial statements for income, balance sheets, and cash flows, along with detailed notes and management's discussion on financial condition and operations. Key areas for investor attention within this report include the company's performance over the nine-month period ending September 30, 2004, and comparative data from the previous year. The report also details HCA's market risk exposures and internal controls. While not providing specific financial figures in this excerpt, the structure of the 10-Q suggests a comprehensive overview of the company's operational and financial health during this period.

Key Highlights

1HCA filed its quarterly report for the period ending September 30, 2004, on November 8, 2004.
2The company is an accelerated filer, indicating a certain level of financial reporting history and size.
3As of October 31, 2004, HCA had approximately 462.2 million shares of voting common stock and 21 million shares of nonvoting common stock outstanding.
4The report includes unaudited condensed consolidated financial statements for income, balance sheets, and cash flows.
5Detailed notes to the financial statements and Management's Discussion and Analysis (MD&A) are provided.
6The filing covers the quarterly period and the nine months ended September 30, 2004, with comparative data for 2003.
7Information on legal proceedings and unregistered sales of equity securities is also included.

HCA Healthcare, Inc. Quarterly Report for Q3 Ended Sep 30, 2004

Summary

Key Highlights

Frequently Asked Questions